CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $405,000 | +108.8% | 7,831 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $194,000 | -2.5% | 7,831 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $199,000 | -42.7% | 7,919 | -16.9% | 0.00% | -50.0% |
| Q4 2021 | $347,000 | +250.5% | 9,534 | +64.4% | 0.00% | +100.0% |
| Q3 2021 | $99,000 | +26.9% | 5,800 | 0.0% | 0.00% | – |
| Q2 2021 | $78,000 | -73.7% | 5,800 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $297,000 | -26.8% | 5,800 | -11.6% | 0.00% | 0.0% |
| Q4 2020 | $406,000 | +68.5% | 6,560 | +49.2% | 0.00% | 0.0% |
| Q3 2020 | $241,000 | -4.7% | 4,398 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $253,000 | +143.3% | 4,398 | +70.1% | 0.00% | +100.0% |
| Q1 2020 | $104,000 | +2.0% | 2,586 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $102,000 | +1175.0% | 2,586 | +131.1% | 0.00% | – |
| Q3 2019 | $8,000 | -20.0% | 1,119 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | – | 1,119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |